Why is it rising? Why is it falling? Some explanations on the unusual variations which affect shares during the day’s session on European markets. Only when they are reliable and documented: we avoid telling nonsense as much as possible. Variations are taken at the time of writing the article.
Rising
Genus (+19%): The biotechnology and genetics company says it is on track to present figures above expectations this year.
Currys (+12%): The London-based electronics retailer announced plans to restore dividend payments and guided its investors to an annual profit above market expectations. Currys forecasts a profit of between £145 million and £155 million this year, above the consensus of £140 million.
Diploma (+4%): The holding company announced quarterly sales up 12% and organic growth of 7%. Diploma maintains its guidance for the full year (fiscal year shifted), targeting organic revenue growth of around 6% and an operating margin of around 21%.
Cellnex Telecom (+5%): The Spanish telecommunications company announced an 800 million euro share buyback program.
Bayer (+2%): The German pharmaceutical group suffers another legal defeat in the United States concerning the health effects of PCB chemistry banned for decades. Bayer was ordered to pay $100 million in damages to four plaintiffs. In business, however, Bayer said it was optimistic thanks to disruptive innovations and expects a return to growth in its pharmaceutical division from 2027. The company is currently focused on reducing its debt and does not plan large acquisitions in the coming years. Bayer insists that size is not a factor for success in the pharmaceutical sector, but rather innovation.
Declining
SGS et Bureau Veritas (-5% / +3%): The two world leaders in the field of inspection and certification are in discussions for a potential merger. If it materializes, this merger would create a company with a market value of nearly 32 billion euros.
Assystem (-10%): Oddo BHF downgraded its opinion on Assystem from ‘outperform’ to ‘neutral’, with a price target reduced from 53 to 44 euros, due to more mixed short-term momentum and relay of growth not powerful enough at this stage.
Borussia Dortmund (-6%): The football club is doing badly and is falling in the rankings of the German championship. Stocks are at their lowest level since 2013.
Belgium
